Adefovir Dipivoxil
2 NDCs across 2 manufacturers|2 Generic,0 Brand
Adefovir Dipivoxil is used to treat chronic hepatitis b, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Sep 20, 2002, and the first generic was approved Aug 29, 2013. FDA's Orange Book lists 2 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $2 million on Adefovir Dipivoxil across 2,545 claims for 390 beneficiaries.
Adefovir Dipivoxil is available as 2 NDCs from 2 manufacturers (2 generic, 0 brand), with NADAC prices from $21.73 to $21.73 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
2G / 0B
Manufacturers
2
competing in market
Price Spread
$21.73 – $21.73
per EA
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Sigmapharm Laboratories LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
2 manufacturers producing ADEFOVIR DIPIVOXIL
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ADEFOVIR DIPIVOXIL 10 MG TAB | $21.7313 per EA | — |
ADEFOVIR DIPIVOXIL 10 MG TAB | $21.7313 per EA | — |
Frequently Asked Questions
What is Adefovir Dipivoxil used to treat?
Adefovir Dipivoxil is used to treat chronic hepatitis b, per the National Library of Medicine's MED-RT classification.
When did Adefovir Dipivoxil become available as a generic?
FDA approved the first generic Adefovir Dipivoxil (ANDA) on Aug 29, 2013. The Orange Book currently lists 2 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Adefovir Dipivoxil?
In 2024, Medicare Part D spent $2 million on Adefovir Dipivoxil across 2,545 claims for 390 beneficiaries.
How many Adefovir Dipivoxil products are on the market?
The Adefovir Dipivoxil drug market contains 2 NDCs from 2 manufacturers — 2 generic and 0 brand products.
What is the price range for Adefovir Dipivoxil?
NADAC reference prices for Adefovir Dipivoxil range from $21.7313 to $21.7313 per EA.
Which manufacturers make Adefovir Dipivoxil?
2 manufacturers list Adefovir Dipivoxil in NADAC. Ranked by number of NDCs, the largest are Sigmapharm Laboratories LLC (1), Apotex Corp. (1).